5-alpha reductase inhibitors (5-ARIs): Label Change – Increased Risk of Prostate Cancer

Audience: Urology, Family Medicine, Internal Medicine Drugs in the 5-ARI class include finasteride and dutasteride. These drugs are marketed under the brand-names Proscar, Propecia, Avodart, and Jalyn
ISSUE: FDA notified healthcare professionals…

Related posts:

1. Zocor (simvastatin): Label Change – New Restrictions, Contraindications, and Dose Limitations Audience: Family Practice, Cardiology, Pharmacy Simvastatin sold under the brand-name...
2. Kaletra (lopinavir/ritonavir): Label Change – Serious Health Problems in Premature Babies Audience: Infectious Disease ISSUE: FDA notified healthcare professionals of serious...
3. Topamax (topiramate): Label Change – Risk For Development of Cleft Lip and/or Cleft Palate in Newborns Audience: Neurology, OB/GYN ISSUE: FDA notified healthcare professionals and patients...